Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafik Terra

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Current Oncology (Toronto, Ont.)|October 28, 2025
From Chronic Lymphocytic Leukemia to Plasmablastic Myeloma: Beyond the Usual Richter TransformationMathias Castonguay, Marie-France Gagnon, Alexandre Le Nguyen, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell TransplantRichard LeBlanc, Stéphanie Thiant, Rafik Terra, et al.
Transplantation and Cellular Therapy|October 17, 2024
A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma PatientsJean Roy, Sandra Cohen, Guy Sauvageau, et al.
Bone Marrow Transplantation|November 30, 2021
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II studyRichard LeBlanc, Imran Ahmad, Rafik Terra, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Current Oncology (Toronto, Ont.)|October 28, 2025
From Chronic Lymphocytic Leukemia to Plasmablastic Myeloma: Beyond the Usual Richter TransformationMathias Castonguay, Marie-France Gagnon, Alexandre Le Nguyen, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell TransplantRichard LeBlanc, Stéphanie Thiant, Rafik Terra, et al.
Transplantation and Cellular Therapy|October 17, 2024
A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma PatientsJean Roy, Sandra Cohen, Guy Sauvageau, et al.
Bone Marrow Transplantation|November 30, 2021
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II studyRichard LeBlanc, Imran Ahmad, Rafik Terra, et al.
Pageof 2